Published in Stem Cells Transl Med on March 06, 2014
Differentiation of human limbal-derived induced pluripotent stem cells into limbal-like epithelium. Stem Cells Transl Med (2014) 0.93
Autologous, allogeneic, induced pluripotent stem cell or a combination stem cell therapy? Where are we headed in cartilage repair and why: a concise review. Stem Cell Res Ther (2015) 0.80
Amyloid precursor protein expression and processing are differentially regulated during cortical neuron differentiation. Sci Rep (2016) 0.77
From gristle to chondrocyte transplantation: treatment of cartilage injuries. Philos Trans R Soc Lond B Biol Sci (2015) 0.76
iPS-derived MSCs from an expandable bank to deliver a prodrug-converting enzyme that limits growth and metastases of human breast cancers. Cell Death Discov (2017) 0.75
Enhanced non-viral gene delivery by coordinated endosomal release and inhibition of β-tubulin deactylase. Nucleic Acids Res (2016) 0.75
Extracellular Matrix-Dependent Generation of Integration- and Xeno-Free iPS Cells Using a Modified mRNA Transfection Method. Stem Cells Int (2016) 0.75
Regenerative rehabilitation: a new future? Am J Phys Med Rehabil (2014) 0.75
Equine-Induced Pluripotent Stem Cells Retain Lineage Commitment Toward Myogenic and Chondrogenic Fates. Stem Cell Reports (2016) 0.75
Induced pluripotent stem cells in dentistry. J Pharm Bioallied Sci (2016) 0.75
Knockdown of the cell cycle inhibitor p21 enhances cartilage formation by induced pluripotent stem cells. Tissue Eng Part A (2015) 0.75
Cellular reprogramming for clinical cartilage repair. Cell Biol Toxicol (2017) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Induced pluripotent stem cell lines derived from human somatic cells. Science (2007) 71.50
Multilineage potential of adult human mesenchymal stem cells. Science (1999) 66.19
Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet (2000) 21.52
Human induced pluripotent stem cells free of vector and transgene sequences. Science (2009) 17.16
Generation of mouse induced pluripotent stem cells without viral vectors. Science (2008) 15.25
Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med (1994) 14.46
Epigenetic memory in induced pluripotent stem cells. Nature (2010) 14.31
Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell (2010) 14.18
Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature (2011) 13.94
Induced pluripotent stem cells generated without viral integration. Science (2008) 13.38
Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell (2009) 13.02
piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature (2009) 11.27
Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol (2010) 9.24
Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell (2009) 8.62
Copy number variation and selection during reprogramming to pluripotency. Nature (2011) 8.24
A more efficient method to generate integration-free human iPS cells. Nat Methods (2011) 7.39
Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci U S A (2010) 7.31
Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell (2010) 7.16
Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell (2011) 6.82
Variation in the safety of induced pluripotent stem cell lines. Nat Biotechnol (2009) 6.39
A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell (2008) 5.99
A nonviral minicircle vector for deriving human iPS cells. Nat Methods (2010) 4.42
The control of chondrogenesis. J Cell Biochem (2006) 4.36
Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon. Nat Methods (2009) 4.27
Premature induction of hypertrophy during in vitro chondrogenesis of human mesenchymal stem cells correlates with calcification and vascular invasion after ectopic transplantation in SCID mice. Arthritis Rheum (2006) 4.16
DNA demethylation is necessary for the epigenetic reprogramming of somatic cell nuclei. Nat Cell Biol (2004) 3.89
Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells. Nat Biotechnol (2011) 3.25
Stoichiometric and temporal requirements of Oct4, Sox2, Klf4, and c-Myc expression for efficient human iPSC induction and differentiation. Proc Natl Acad Sci U S A (2009) 2.86
Cellular interactions and signaling in cartilage development. Osteoarthritis Cartilage (2000) 2.77
Generation of mouse-induced pluripotent stem cells by transient expression of a single nonviral polycistronic vector. Proc Natl Acad Sci U S A (2009) 2.44
Autologous chondrocyte implantation: a long-term follow-up. Am J Sports Med (2010) 2.43
Polycistronic lentiviral vector for "hit and run" reprogramming of adult skin fibroblasts to induced pluripotent stem cells. Stem Cells (2009) 2.01
Recurrent copy number variations in human induced pluripotent stem cells. Nat Biotechnol (2011) 1.98
Karotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells. Nat Biotechnol (2011) 1.85
Differential expression of a cysteine-rich domain in the amino-terminal propeptide of type II (cartilage) procollagen by alternative splicing of mRNA. J Biol Chem (1990) 1.75
Directed differentiation of human embryonic stem cells toward chondrocytes. Nat Biotechnol (2010) 1.72
Elevated coding mutation rate during the reprogramming of human somatic cells into induced pluripotent stem cells. Stem Cells (2012) 1.62
A defined Oct4 level governs cell state transitions of pluripotency entry and differentiation into all embryonic lineages. Nat Cell Biol (2013) 1.45
Phenotypic plasticity of human articular chondrocytes. J Bone Joint Surg Am (2003) 1.21
Differentiating human embryonic stem cells express a unique housekeeping gene signature. Stem Cells (2007) 1.18
High resolution array-CGH characterization of human stem cells using a stem cell focused microarray. Mol Biotechnol (2010) 1.11
Autologous chondrocyte implantation in cartilage lesions of the knee: long-term evaluation with magnetic resonance imaging and delayed gadolinium-enhanced magnetic resonance imaging technique. Am J Sports Med (2010) 1.09
Human induced pluripotent stem cells differentiated into chondrogenic lineage via generation of mesenchymal progenitor cells. Stem Cells Dev (2012) 0.98
Adaptation of human embryonic stem cells to feeder-free and matrix-free culture conditions directly on plastic surfaces. J Biotechnol (2007) 0.92
Human serum for culture of articular chondrocytes. Cell Transplant (2005) 0.80
Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol (2007) 9.36
Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol (2011) 3.97
Genomic alterations in cultured human embryonic stem cells. Nat Genet (2005) 3.89
Human embryonic stem cells have a unique epigenetic signature. Genome Res (2006) 2.89
Autologous chondrocyte implantation: a long-term follow-up. Am J Sports Med (2010) 2.43
Autologous chondrocyte transplantation. Biomechanics and long-term durability. Am J Sports Med (2002) 2.36
Treatment of osteochondritis dissecans of the knee with autologous chondrocyte transplantation: results at two to ten years. J Bone Joint Surg Am (2003) 2.24
Derivation, characterization, and differentiation of human embryonic stem cells. Stem Cells (2004) 1.89
Nuclei of adult mammalian somatic cells are directly reprogrammed to oct-4 stem cell gene expression by amphibian oocytes. Curr Biol (2003) 1.76
Genetic and epigenetic factors are associated with expression of respiratory chain component NDUFB6 in human skeletal muscle. J Clin Invest (2007) 1.65
Articular cartilage engineering with autologous chondrocyte transplantation. A review of recent developments. J Bone Joint Surg Am (2003) 1.44
Creation of engineered human embryonic stem cell lines using phiC31 integrase. Stem Cells (2007) 1.35
Facilitated expansion of human embryonic stem cells by single-cell enzymatic dissociation. Stem Cells (2007) 1.32
Derivation of a xeno-free human embryonic stem cell line. Stem Cells (2006) 1.26
Transplantation of human mesenchymal stems cells into intervertebral discs in a xenogeneic porcine model. Spine (Phila Pa 1976) (2009) 1.26
Proliferation and differentiation potential of chondrocytes from osteoarthritic patients. Arthritis Res Ther (2005) 1.23
Chondrogenic differentiation potential of osteoarthritic chondrocytes and their possible use in matrix-associated autologous chondrocyte transplantation. Arthritis Res Ther (2009) 1.21
Differentiating human embryonic stem cells express a unique housekeeping gene signature. Stem Cells (2007) 1.18
Molecular signature of cardiomyocyte clusters derived from human embryonic stem cells. Stem Cells (2008) 1.16
Human embryonic stem cell-derived mesenchymal progenitors--potential in regenerative medicine. Stem Cell Res (2009) 1.16
Human embryonic mesodermal progenitors highly resemble human mesenchymal stem cells and display high potential for tissue engineering applications. Tissue Eng Part A (2010) 1.15
Gene expression during redifferentiation of human articular chondrocytes. Osteoarthritis Cartilage (2004) 1.15
Identification of cell proliferation zones, progenitor cells and a potential stem cell niche in the intervertebral disc region: a study in four species. Spine (Phila Pa 1976) (2009) 1.14
Improving expansion of pluripotent human embryonic stem cells in perfused bioreactors through oxygen control. J Biotechnol (2010) 1.12
Monitoring differentiation of human embryonic stem cells using real-time PCR. Stem Cells (2005) 1.11
Differentiation of human embryonic stem cells to cardiomyocytes for in vitro and in vivo applications. Stem Cell Rev (2010) 1.09
Autologous chondrocyte implantation in cartilage lesions of the knee: long-term evaluation with magnetic resonance imaging and delayed gadolinium-enhanced magnetic resonance imaging technique. Am J Sports Med (2010) 1.09
C-kit+ CD45- cells found in the adult human heart represent a population of endothelial progenitor cells. Basic Res Cardiol (2010) 1.09
Identification of a stem cell niche in the zone of Ranvier within the knee joint. J Anat (2009) 1.09
Coculture of human embryonic stem cells and human articular chondrocytes results in significantly altered phenotype and improved chondrogenic differentiation. Stem Cells (2009) 1.06
Differentiation of human mesenchymal stem cells and articular chondrocytes: analysis of chondrogenic potential and expression pattern of differentiation-related transcription factors. J Orthop Res (2007) 1.06
The application of human embryonic stem cell technologies to drug discovery. Drug Discov Today (2007) 1.03
Studies of polyurethane urea bands for ACL reconstruction. J Mater Sci Mater Med (2002) 1.02
Human embryonic stem cell technologies and drug discovery. J Cell Physiol (2009) 1.00
Indentation stiffness of repair tissue after autologous chondrocyte transplantation. Clin Orthop Relat Res (2005) 0.96
Osteogenic potential of human mesenchymal stem cells and human embryonic stem cell-derived mesodermal progenitors: a tissue engineering perspective. Tissue Eng Part A (2010) 0.96
Notch and HES5 are regulated during human cartilage differentiation. Cell Tissue Res (2006) 0.96
Autologous chondrocyte transplantation of the ankle. Foot Ankle Clin (2003) 0.94
Secular trends in sex hormones and fractures in men and women. Eur J Endocrinol (2012) 0.93
Human embryonic stem cells: current technologies and emerging industrial applications. Crit Rev Oncol Hematol (2007) 0.93
Adaptation of human embryonic stem cells to feeder-free and matrix-free culture conditions directly on plastic surfaces. J Biotechnol (2007) 0.92
Malalignment and cartilage lesions in the patellofemoral joint treated with autologous chondrocyte implantation. Knee Surg Sports Traumatol Arthrosc (2010) 0.92
Transplantation of human embryonic stem cells onto a partially wounded human cornea in vitro. Acta Ophthalmol (2012) 0.91
Evaluation of p16 and Id1 status and endogenous reference genes in human chondrosarcoma by real-time PCR. Int J Oncol (2005) 0.89
Clonal derivation and characterization of human embryonic stem cell lines. J Biotechnol (2005) 0.89
Articular cartilage stem cell signalling. Arthritis Res Ther (2009) 0.89
Expression of genes involved in the regulation of p16 in psoriatic involved skin. Arch Dermatol Res (2006) 0.88
Support of concept that migrating progenitor cells from stem cell niches contribute to normal regeneration of the adult mammal intervertebral disc: a descriptive study in the New Zealand white rabbit. Spine (Phila Pa 1976) (2012) 0.88
Neither Notch1 expression nor cellular size correlate with mesenchymal stem cell properties of adult articular chondrocytes. Cells Tissues Organs (2008) 0.88
Poly-L-D-lactic acid scaffold in the repair of porcine knee cartilage lesions. Tissue Eng (2007) 0.87
Translationally controlled tumor protein interacts with nucleophosmin during mitosis in ES cells. Cell Cycle (2010) 0.87
Landscape of current and emerging cell therapy clinical trials in the UK: current status, comparison to global trends and future perspectives. Regen Med (2015) 0.87
Core transcription factors, Oct4, Sox2 and Nanog, individually form complexes with nucleophosmin (Npm1) to control embryonic stem (ES) cell fate determination. Aging (Albany NY) (2010) 0.87
Strategies for patient profiling in articular cartilage repair of the knee: a prospective cohort of patients treated by one experienced cartilage surgeon. Knee Surg Sports Traumatol Arthrosc (2012) 0.86
Differential bone-forming capacity of osteogenic cells from either embryonic stem cells or bone marrow-derived mesenchymal stem cells. J Tissue Eng Regen Med (2010) 0.86
The presence of local mesenchymal progenitor cells in human degenerated intervertebral discs and possibilities to influence these in vitro: a descriptive study in humans. Stem Cells Dev (2012) 0.85
Phosphorylated nucleolin interacts with translationally controlled tumor protein during mitosis and with Oct4 during interphase in ES cells. PLoS One (2010) 0.85
Sustained embryoid body formation and culture in a non-laborious three dimensional culture system for human embryonic stem cells. Cytotechnology (2011) 0.85
Assaying cardiac biomarkers for toxicity testing using biosensing and cardiomyocytes derived from human embryonic stem cells. J Biotechnol (2010) 0.84
Human adipose-derived stem cells contribute to chondrogenesis in coculture with human articular chondrocytes. Tissue Eng Part A (2009) 0.84
Regulation of 'stemness' and stem cell differentiation by microRNAs. IDrugs (2009) 0.83
Left atrium of the human adult heart contains a population of side population cells. Basic Res Cardiol (2012) 0.83
Expression of microRNAs and their target mRNAs in human stem cell-derived cardiomyocyte clusters and in heart tissue. Physiol Genomics (2010) 0.83
Identification of AHNAK as a novel autoantigen in systemic lupus erythematosus. Biochem Biophys Res Commun (2002) 0.83
RP59, a marker for osteoblast recruitment, is also detected in primitive mesenchymal cells, erythroid cells, and megakaryocytes. Dev Dyn (2002) 0.83
Long-term maintenance of human articular cartilage in culture for biomaterial testing. Biomaterials (2005) 0.83
Superior osteogenic capacity of human embryonic stem cells adapted to matrix-free growth compared to human mesenchymal stem cells. Tissue Eng Part A (2010) 0.83
Human articular chondrocytes--plasticity and differentiation potential. Cells Tissues Organs (2006) 0.83
Cardiomyocyte clusters derived from human embryonic stem cells share similarities with human heart tissue. J Mol Cell Biol (2010) 0.82
Hash4, a novel human achaete-scute homologue found in fetal skin. Genomics (2004) 0.82
Transcriptional profiling of human embryonic stem cells differentiating to definitive and primitive endoderm and further toward the hepatic lineage. Stem Cells Dev (2010) 0.82
Similar cellular migration patterns from niches in intervertebral disc and in knee-joint regions detected by in situ labeling: an experimental study in the New Zealand white rabbit. Stem Cell Res Ther (2013) 0.82
Persisting high levels of synovial fluid markers after cartilage repair: a pilot study. Clin Orthop Relat Res (2008) 0.81
Effects of high mobility group box protein-1, interleukin-1β, and interleukin-6 on cartilage matrix metabolism in three-dimensional equine chondrocyte cultures. Connect Tissue Res (2010) 0.81
The effects of PPAR-γ inhibition on gene expression and the progression of induced osteogenic differentiation of human mesenchymal stem cells. Connect Tissue Res (2014) 0.80
Notch signaling in chondrogenesis. Int Rev Cell Mol Biol (2009) 0.80
Human serum for culture of articular chondrocytes. Cell Transplant (2005) 0.80
Cardiomyocytes derived from human embryonic stem cells - characteristics and utility for drug discovery. Curr Opin Drug Discov Devel (2009) 0.80
High-resolution analysis of the subtelomeric regions of human embryonic stem cells. Stem Cells (2005) 0.80
SAF-A has a role in transcriptional regulation of Oct4 in ES cells through promoter binding. Cell Reprogram (2011) 0.80
SAF-A forms a complex with BRG1 and both components are required for RNA polymerase II mediated transcription. PLoS One (2011) 0.80
The helix-loop-helix transcription factor Id1 is highly expressed in psoriatic involved skin. Acta Derm Venereol (2003) 0.79